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ABSTRACT 
Introduction: 
Inflammation of the lacrimal sac is known as dacryocystitis which usually 
occurs due to obstruction in the nasolacrimal duct. It is a significant cause of ocular 
morbidity in children and adults. It can be congenital or acquired. Acquired 
dacryocystitis can occur as acute and chronic dacryocystitis.  Dacryocystitis is mostly 
caused by bacteria and rarely by fungi. There is a change in etiological agents causing 
dacryocystitis over the time. Hence this study was undertaken to know the etiological 
agents of congenital, acute and chronic dacryocystitis. 
Aims of the study:  
To isolate and identify the bacteria and fungi from clinically diagnosed cases of 
dacryocystitis. To determine the antimicrobial susceptibility pattern of the bacterial 
and fungal isolates. 
Materials and methods: 
A total of 100 clinically diagnosed cases of dacryocystitis of all age groups 
attending the outpatient department at the Regional Institute of Ophthalmology and 
Government Ophthalmic Hospital were included in the study. Samples were collected 
from these patients and processed by standard microbiological techniques.  
Results: 
Dacryocystitis was more common in the age group of 40 to 50 years.12 patients 
of congenital dacryocystitis, 8 patients of acute dacryocystitis and 80 patients of 
chronic dacryocystitis were studied. Females (66%) were more affected than males 
(34%). Left eye (63%) was commonly affected than the right eye (35%)and 2% of 
cases were bilateral. Overall culture positivity was 51.9%. Among the culture positive 
samples, 90.5% yielded single organism and 9.4% yielded mixed organisms. Totally 
58 organisms were isolated, of which 58.6% were Gram positive bacteria, 37.9% were 
Gram negative bacteria, and 3.4% were fungal isolates.Streptococcus pneumoniae was 
the common pathogen in congenital dacryocystitis and Staphylococcus aureus was the 
common pathogen in acute and chronic dacryocystitis. The incidence of Gram 
negative pathogens were more in chronic dacryocystitis.Gram positive bacteria were 
highly sensitive to Gatifloxacin and least sensitive to Ciprofloxacin. Gram negative 
bacteria were highly sensitive to Tobramycin and least sensitive to Ciprofloxacin and 
Gentamicin. Candida albicans was isolated from two cases of chronic dacryocystitis 
and both were sensitive to Amphotericin B, Fluconazole, Voriconazole and 
Itraconazole. 
Conclusion: 
Microbial culture and sensitivity should be performed in all dacryocystitis 
cases. This would contribute to the choice of appropriate and effective antimicrobial 
agents.  
Key words: Dacryocystitis, nasolacrimal duct, Staphylococcus aureus. 
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INTRODUCTION 
Inflammation of the lacrimal sac is known as dacryocystitis which 
usually occurs due to obstruction in the nasolacrimal duct. It has bimodal 
distribution affecting children less than 1 year and adults over 40 years of 
age[1]. It is a significant cause of ocular morbidity in children and adults. This 
disease is more common in patients with poor personal hygiene[2].  
Dacryocystitis is an unpleasant disease, as it causes constant watering 
and discharge. Dacryocystitis is also a threat to the integrity of the eye by 
becoming the source of infection to orbital cellulitis and panophthalmitis[3,4].    
Dacryocystitis can be classified as congenital and acquired 
dacryocystitis. Acquired dacryocystitis can occur as acute and chronic 
dacryocystitis. Chronic dacryocystitis is more common[1]. 
Nasolacrimal duct obstruction(NLD) can occur from different 
aetiologies, such as primary idiopathic obstruction and secondary obstruction 
which finally results in stasis of tears, desquamated cells and mucoid secretions 
in the lacrimal sac, this creates favourable environment for inflammation and 
infection[5,6]. 
The lacrimal drainage system is prone for infection due to, contiguity of 
nasolacrimal duct with conjunctival and nasal mucosal surfaces which are 
usually colonised with bacteria. In turn dacryocystitis can spread to adjoining 
structures because of continuity [3]. 
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Dacryocystitis is mostly caused by bacteria and rarely by fungi. The 
organisms causing dacryocystitis may be different in acute and chronic 
infections. In chronic dacryocystitis mixed infections are more common[5].       
Congenital dacryocystitis is usually presents with epiphora in newborn. 
Later purulent discharge may develop resulting in matting of eyelashes. When 
not treated early, complications such as recurrent conjunctivitis, acute on 
chronic dacryocystitis, lacrimal abscess and fistula formation can occur. 
Acute dacryocystitis usually presents with pain and tenderness over the 
lacrimal sac area. It may present with lacrimal abscess. Complications include 
acute conjunctivitis, lid abscess, orbital cellulitis, acute ethmoiditis and very 
rarely cavernous sinus thrombosis. 
Chronic dacryocystitis is common than the acute one. It usually presents 
with persistent watering and discharge from the eye. Complications like 
chronic conjunctivitis, ectropion of the lower eye lid can occur. Because of 
prolonged watering, eczema and maceration of lower eye lid skin can occur. It 
is an important contributory factor for corneal ulcer development and 
panophthalmitis[7]. 
In Ophthalmology practice, syringing of the nasolacrimal system is 
performed preoperative to cataract surgery, in order to exclude dacryocystitis 
because, it is the risk factor for postoperative infection. If any intraocular 
surgery is done in the presence of unrecognized dacryocystitis, panophthalmitis 
can occur[2].  
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Untreated dacryocystitis will not undergo spontaneous resolution[1]. 
There are several bacteria known to have been implicated as etiological 
agents of dacryocystitis. There is a change in etiological agents causing 
dacryocystitis over the time. So knowing the range of the microorganisms 
causing dacryocystitis and their antibiotic sensitivity pattern in recent times 
may help in choosing the appropriate antimicrobial therapy.                             
There are relatively few studies conducted regarding microbiological 
characteristics of dacryocystitis. Most of them have studied a specific type of 
dacryocystitis.          
Hence this study was undertaken to know the etiological agents of 
congenital, acute and chronic dacryocystitis. 
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AIMS OF THE STUDY 
1. To isolate and identify the bacteria and fungi from clinically diagnosed 
cases of dacryocystitis. 
2. To determine the antibiotic susceptibility pattern of the bacterial 
isolates. 
3. To determine the antifungal susceptibility pattern of fungal isolates 
obtained. 
4. To determine and compare the incidence of the various bacterial agents 
in congenital, acute and chronic cases of dacryocystitis. 
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REVIEW OF LITERATURE 
BACKGROUND: 
Dacryocystitis occurs usually due to lacrimal outflow obstruction. It 
results in stasis of tears in the lacrimal sac. Lacrimal sac infection is usually 
due to bacterial infections. Only in 1.2% of cases dacryocystitis is caused by 
fungal organisms (CodenDj[8]).  
HISTORICAL PERSPECTIVE: 
The disease dacryocystitis has been known from the very earliest times 
due to its manifestations such as abscesses and fistula on the face. It has been 
known as Aegilops in the earliest times. The term, Aegilops include all inner 
canthus swellings. In 1702, George and Sehl of Helle described about Aegilops 
that, it was not the soft tissue affection but a consequence of obstruction to the 
lacrimal outflow which results in inflammation[9]. 
Hirschberg noted that the school of Hippocrates recognized the 
relationship between epiphora and aging[10]. Lacrimal sac abscess and fistula 
formation were reported by the ancient Greeks[11].  
Platner(1724) observed the presence of nasal disease as a source of 
infection to dacryocystitis. Later this fact was stressed by Schirmer(1877) and 
also by Kuhnt(1891-95). 
Truce noticed (1900) high incidence of Dacryocystitis among the people 
in theTropics [12]. 
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The disease commonly occurs in the middle age group, with high 
incidence in the fifth decade and it is rare in adolescents and children. In adults 
it is more common in females than males due to the narrow bony canal in 
females. In the newborn this disease affects both sexes equally. This fact was 
described by Meller(1929), Ruiz Barrabco, Martinez Romain(1966) and others. 
Importance of racial and geographical incidence was described by 
Santos-Femandez, 1903-21. According to them, this disease is rare in Negroes. 
It is because of the presence of shorter and wider canal in Negroes. 
Kofler (1919), Stenger(1920) and Bockstein(1926) observed that, septal 
deflection as a cause of nasolacrimal duct obstruction at the lower end. 
Schaeffer(1920) found that, mucosal abnormalities can produce stasis and also 
obstruction to the lacrimal outflow. 
Dacryocystitis caused by Aspergillosis has been reported by 
Wright(1930) and Rosen Vold(1942). 
Dacryocystitis caused by Candida albicans was reported by Fine and 
Waring(1947). Lacrimal sac abscess due to Candida albicans has been reported 
by Janokta (1970). 
One case of bilateral fungal dacryocystitis caused by Candida albicans 
has been described by Codere F et al in 1982 in a patient who had mid facial 
trauma [13]. 
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EPIDIMIOLOGY OF DACRYOCYSTITIS: 
FREQUENCY:  
Individuals having brachycephalic heads will have a higher incidence of 
dacryocystitis than those having dolichocephalic and mesocephalic heads. This 
is because; brachycephalic skulls have a narrow diameter of inlet in to the 
nasolacrimal duct. Individuals having flat nose and narrow face are more prone 
for development of dacryocystitis. This may be due to the presence of the 
narrow osseous canal in these individuals[14]. 
 
MORBIDITY AND MORTALITY: 
In acute dacryocystitis patients will have severe morbidity and rarely 
mortality. Morbidity is primarily due to lacrimal abscess and spreading of 
infection. 
The morbidity in chronic dacryocystitis is due to chronic watering, 
matting of eyelashes and inflammation, infection of conjunctiva. 
Congenital dacryocystitis is associated with both morbidity and 
mortality. If not treated properly on time, orbital cellulitis can occur in 
newborns as orbital septum is poorly formed in them. Other complications like, 
brain abscess, meningitis and sepsis can occur in congenital dacryocystitis[14, 
15]. 
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ANATOMY OF THE LACRIMAL DRAINAGE SYSTEM 
The lacrimal apparatus consists of the following structures[16]: 
1. Lacrimal gland- secretes tears, 
2. Lacrimal punctum, 
3. Lacrimal canaliculi, 
4. Lacrimal sac, 
5. Nasolacrimal duct- carries tears in to nasal cavity. 
 
 
 
 
 
 
 
Fig 1: Anatomy of the lacrimal apparatus. 
Lacrimal gland: 
The lacrimal gland of each eye has an orbital gland, a palpebral gland 
and accessory lacrimal glands. The orbital gland is situated in the fossa in the 
orbital roof. Its ducts open upon the conjunctival surface at the upper fornix. 
The palpebral gland is situated on the course of superior portion ducts. The 
accessory glands which are microscopic acini, situated below the conjunctival 
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surface between the fornix and tarsus edge. The ducts of acini, by forming a 
large duct open in to the fornix.  
Lacrimal punctum:  
Each eye lid has one punctum. It is situated near the posterior border of 
the eye lid, 6 mm from the medial canthus. 
Lacrimal canaliculi:  
Each eye lid has one canaliculi. It starts at the punctum. First it is 
directed vertically for 2 mm and it turns at the ampulla and then it runs 
horizontally for 6 to 7 mm. A common canaliculi is formed by the union of 
upper and lower canaliculi and opens in to the lacrimal sac. A fold of mucosa at 
this area forms the valve of Rosenmuller. This valve prevents the reflux of 
tears. The walls of canaliculi are lined by stratified squamous epithelium. 
Lacrimal sac: 
It is situated in the lacrimal fossa. The lacrimal fossa is formed by 
frontal process of maxilla and lacrimal bone. The sac is enclosed by lacrimal 
fascia. The upper part of the sac is the fundus. When distended it is 15 mm long 
and 5 mm wide. The lower end opens in to the nasolacrimal duct.  A fibrous 
expansion derived from the medial palpebral ligament covers the superficial 
surface of the lacrimal sac.  Lacrimal part of the orbicularis oculi muscle 
crosses its deep surface. The wall of lacrimal sac is lined by columnar cells. 
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Nasolacrimal duct: 
It is 18 mm long. It connects the lower end of lacrimal sac with the 
inferior turbinate of the nose. In the middle part it is narrower than the both 
ends. The nasolacrimal duct is lodged in the nasolacrimal bony canal, which 
lies between the nasal cavity and the maxillary sinus. It runs downwards, 
slightly outwards and backwards. It opens at the anterior part of inferior meatus 
of the nose. A mucosal flap forms the valve of Hasner close this opening when 
necessary. The nasolacrimal duct is lined by columnar cells. 
 
PHYSIOLOGY OF THE LACRIMAL DRAINAGE SYSTEM[1, 17] 
Tears secreted by the lacrimal glands pass across the ocular surface, a 
variable amount of which is lost by evaporation. This is related to blink rate, 
ambient temperature, humidity and the size of the palpebral aperture. The 
remaining tears drain as follows(Fig 2): 
 Tears flow along the upper and lower marginal strips and it enters by 
capillary action and suction into the upper and lower canaliculi(Fig 2 A). 
 With each blink of eye, the pretarsal orbicularis oculi compresses the 
ampullae and thereby shortens the horizontal canaliculi and moves the 
puncta medially. At the same time, the lacrimal part of the orbicularis 
oculi contracts and compresses the sac, as it is attached to the fascia of 
the lacrimal sac. This creates a positive pressure which forces tears 
down the nasolacrimal duct and in to the nose(Fig 2 B &C). 
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 When the eyes open, the muscles relax; the lacrimal sac and canaliculi 
expand and creates a negative pressure which draws the tears from the 
eye in to the empty lacrimal sac. 
 
 
 
 
 
(A)   (B)   (C)  
Fig 2: Physiology of the lacrimal drainage system. 
 
The tear film provides smooth surface for the movement of the eyelids, 
facilitates the passage of the light, lubricates and provides nutrition to the 
cornea, and also protects the eyes from injury and infection. Owing to the 
presence of enzyme lysozyme, the tears have some bacteriostatic 
properties.The lacrimal secretion has slightly alkaline properties and has 
sodium chloride as its chief constituents. The normal lacrimal secretion is just 
sufficient to moisten the eyeball. 
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DACRYOCYSTITIS 
Dacryocystitis is defined as inflammation of the lacrimal sac. It occurs 
due to obstruction in the nasolacrimal duct. It is an unpleasant disease, because 
it can cause conspicuous watering and has minimum tendency to resolve. 
Nasolacrimal duct obstruction can occur from different aetiologies, such as 
primary idiopathic obstruction or secondary obstruction.  
The reasons for secondary obstruction include stricture of the duct 
caused by chronic atrophic rhinitis, obstruction due to lacrimal sac tumours and 
maxillary sinusitis; obstruction of the distal end of the duct due to nasal polyp 
or inferior turbinate hypertrophy. Tuberculosis, syphilis and leprosy-originating 
from the surrounding bones or  nose can also cause secondary obstruction 
[18].All the above conditions results in stasis of tears, desquamated cells and 
mucoid secretions in the lacrimal sac, which creates favourable environment 
for infection. The infection is mostly due to bacteria and rarely due to fungi.  
Dacryocystitis is treated with topical, systemic antibiotics, probing and silicone 
stent intubation. Surgery can be done to re-establish the duct patency[19]. 
Dacryocystitis can occur in two forms, congenital dacryocystitis and 
acquired dacryocystitis. 
CONGENITAL DACRYOCYSTITIS  
Etiology: 
Congenital dacryocystitis occurs due to congenital blockage of the 
nasolacrimal duct, which results from incomplete canalization of the 
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nasolacrimal duct especially at the valve of Hasner. It is also known as 
dacryocystitis neonatorum [20]. The common bacteria associated with this 
condition are Staphylococci, Pneumococci and Streptococci[21]. 
Clinical presentation: 
 Epiphora- develops seven days after birth, 
 Positive regurgitation test - when pressure is applied over the lacrimal 
sac area, there may be a mucoid or mucopurulent regurgitation through 
the puncta, 
 Swelling over the sac area may appear. 
Complications:   
If it is not treated early, complications like, 
 Recurrent conjunctivitis, 
 Acute on chronic dacryocystitis, 
 Lacrimal abscess and formation of fistula    can occur[21].   
ACQUIRED DACRYOCYSTITIS: 
Acquired dacryocystitis can occur both as acute and chronic 
dacryocystitis. Chronic dacryocystitis is more common. 
ACUTE DACRYOCYSTITIS: 
Acute dacryocystitis is an acute lacrimal sac inflammation. 
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Etiology: 
It may develop due to direct involvement from infected para nasal 
sinuses, dental abscess or caries teeth or, as an acute exacerbation of chronic 
dacryocystitis. The most common organisms responsible are Staphylococcus 
aureus and Streptococcus species[22]. 
Clinical presentation:  
It can be divided in to three stages. 
1. Stage of cellulitis:  
It presents with, 
 Painful swelling over the lacrimal sac area, 
 Epiphora, 
 Fever and malaise, 
 Spread of edema to eyelids and cheeks.  
2. Stage of lacrimal abscess:  
Continuation of inflammation results in occlusion of canaliculi. The 
lacrimal sac is filled with pus. It presents with large fluctuant swelling pointing 
below and outer part of the sac. 
3. Stage of fistula formation:  
If lacrimal abscess is not treated, it spontaneously discharges and 
external fistula will be formed[21]. 
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Complications:  
It includes, 
 Mucocele,  
 Fistula formation, 
 Chronic conjunctivitis, 
 Orbital cellulitis. 
CHRONIC DACRYOCYSTITIS 
Chronic dacryocystitis is more common than the acute one. 
Etiology:  
The etiological factors are grouped as, 
I.Predisposing factors 
Age: It is more common over 40 years of age. 
Sex: It is more common in females because of comparatively narrow 
bony canal lumen. As it coincides with menopausal age, an endocrine 
basis can be suggested. Due to endocrine changes, hypertrophy of the 
mucous membrane can occur, which will be infected easily and leads to 
obstruction of nasolacrimal duct[18]. 
Heredity: It may play a role by affecting the facial configuration with 
respect to the length and width of the NLD. 
Poor personal hygiene: It is another predisposing factor. 
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II. Factors result in stasis of tears in lacrimal sac 
Anatomical factor: Those who are having narrow bony canal are at risk 
of developing this condition. 
Excessive lacrimation: Primary and reflux lacrimation can cause 
stagnation of tears in the lacrimal sac. 
Mild inflammation of sac: It can occur due to recurrent conjunctivitis. 
The epithelial debris,mucus plugs will block the NLD. 
Lower end NLD obstruction: This can occur due to nasal diseases 
such as, nasal polyps, inferior turbinate hypertrophy, deviated nasal 
septum, stenosis caused by atrophic rhinitis[21, 23]. 
III. Source of infection:  
Infection can spread from conjunctiva, nasal cavity, paranasal sinuses. 
IV. Causative microorganisms: 
Staphylococcus species, Pneumococcus species, Pseudomonas species 
are common infective organisms[21].  
Clinical presentation:  
It is divided in to four stages. 
1.Stage of catarrhal dacryocystitis: The only symptom at this stage is 
watering from the eye. 
2.Stage of lacrimal mucocele:  At this stage patients present with 
constant epiphora, with swelling below the inner canthus region. On 
17 
 
pressing the swelling there will be mucoid discharge regurgitates from 
the lower punctum.  
3.Stage of chronic suppurative dacryocystitis: At this stage, because 
of pyogenic infections, the mucoid discharge will become purulent. The 
mucocele is converted to pyocele. Patients present with, epiphora, 
recurrent conjunctivitis and swelling at the medial canthus. On pressing 
the swelling there will be frank purulent discharge which regurgitates 
from the lower punctum. 
4.Stage of chronic fibrotic sac:  Due to repeated infections, a small 
fibrotic sac will develop. Patients present with persistent epiphora and 
discharge.  
 
Complications: 
 Chronic conjunctivitis 
 Acute on chronic dacryocystitis 
 Ectropion of the lower eye lid 
 Corneal abrasions, which can be infected and leads to hypopyon 
corneal ulcer, 
 Risk of development of endophthalmitis, if any intraocular 
surgery is performed in dacryocystitis patients[21]. 
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CLINICAL EVALUATION OF THE NASOLACRIMAL SYSTEM 
Examination by diffuse illumination using magnification:  
This test is done to rule out causes of reflex hypersecretion located in 
eye lids, conjunctiva and cornea.  
Regurgitation test:  
In this test, steady pressure is applied over the lacrimal sac area. Reflux 
of watery, mucoid or mucopurulent discharge through the punctum indicates 
obstruction in the nasolacrimal duct. 
Syringing[24]:  
In this test, after instillation of topical anaesthetic agent, with the help of 
Nettleship punctum dilator, the lower punctum is dilated. Then saline is 
injected through a smooth tipped cannula passed into the lacrimal canaliculi. If 
saline passes into the nose or throat freely, it indicates a patent nasolacrimal 
duct. In the presence of nasolacrimal duct obstruction, the fluid will regurgitate 
through the upper punctum. 
Fluorescein dye disappearance test[25]:  
Apart from syringing it is probably the single most useful test.  A drop 
of 2% fluorescein should be placed in the lower fornix of the both eyes and left 
for 5 minutes. If the eye remains yellow and the tear meniscus is raised, it is 
suggestive of abnormality in tear drainage. This test is particularly useful in 
unilateral epiphora as the normal side goes white and the abnormal side 
remains yellow.  
19 
 
Nasal endoscopy:  
This is helpful in evaluation of diseases of nasal septum and 
turbinate[14].  
Dacryocystography[26]:  
This is used to know the level of obstruction. To perform the procedure, 
a radiopaque material such as lipiodol is pushed into the lacrimal sac by using a 
lacrimal cannula. Then X rays are taken after 5 and 30 minutes for visualisation 
of the entire passage.  
CT scan:  
This is useful in craniofacial injuries, congenital craniofacial 
deformities. It also helps in evaluation of concomitant sinus or nasal 
diseases[27]. 
 
MANAGEMENT OF CONGENITAL DACRYOCYSTITIS[21]: 
 Up to 6-8 weeks of age: 
Massage over the lacrimal sac area should be done at least 4 times per 
day. This should be followed by installation of antibiotic drops. This 
method can cure 90% of infants. 
 Up to 2 months of age:  
If the condition is not cured by the above management, lacrimal 
syringing with normal saline can be done. It should be followed by 
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antibiotic installation. Syringing should be carried out once or twice a 
week. 
 Up to 3-4 months of age:  
If the condition is not cured by syringing, Probing of nasolacrimal duct 
with Bowman’s probe can be done. It is performed under general 
anaesthesia. If it is failed the same procedure can be repeated after one 
month. 
 Up to 4 years: 
Conservative treatment like, massaging, topical antibiotics and 
intermittent syringing should be done up to 4 years of age. 
 After 4 years of age: 
Dacryocystorhinostomy surgery can be performed. 
MANAGEMENT OF ACUTE DACRYOCYSTITIS: 
At the Stage of cellulitis: 
At this stage, treatment consists of systemic antibiotics and anti-
inflammatory drugs with hot fomentation. 
At the Stage of lacrimal abscess:  
At this stage, in addition to the antibiotics, incision & drainage should 
be performed. Later, to prevent recurrence, either Dacryocystectomy or 
Dacryocystorhinostomy surgery can be performed, depending on the lacrimal 
sac condition. 
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At the Stage of fistula formation:  
Fistulectomy along with Dacryocystectomy or Dacryocystorhinostomy 
can be done. 
MANAGEMENT OF CHRONIC DACRYOCYSTITIS: 
Conservative treatment: 
In the early period, repeated lacrimal syringing can be done. Antibiotics 
should be given. 
Surgical procedures:  
1. Dacryocystorhinostomy (DCR): 
 It is the preferred surgery because the lacrimal drainage is reestablished. 
The infection should be controlled before doing the surgery. DCR can be 
performed either by conventional external approach or by endo nasal DCR. 
2.Dacryocystectomy (DCT):  
When DCR is contraindicated, this surgery can be performed. 
Indications are,  
 Patients more than 60 years of age, 
 Presence of shrunken and fibrosed sac, 
 Infections with tuberculosis, leprosy and mycotic infections 
 Lacrimal sac tumours 
 Nasal diseases particularly atrophic rhinitis 
3.Conjunctivodacryocystorhinostomy:  
This surgery is done, if blocked canaliculi are present[21]. 
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MICROBIOLOGY OF DACRYOCYSTITIS 
Normal flora of the conjunctiva: 
The predominant organisms of the conjunctiva include, diphtheroids 
mainly Corynebacterium xerosis, Moraxella species, Staphylococcus 
epidermidis and nonhemolytic Streptococci. Normally the conjunctival flora is 
held in check by the flow of tears and the antibacterial lysozyme it 
contain[28,29]. 
Bacterial and fungal profile of dacryocystitis: 
Because of the contiguity of mucous lined tract of the lacrimal drainage 
system with conjunctival and nasal mucosal surfaces, organisms from both 
ends of lacrimal passage can infect the lacrimal sac. Infection from para nasal 
sinuses and oral cavity can also spread to the sac. 
The common bacteria causing dacryocystitis are Streptococcus 
pneumoniae, Staphylococcus aureus, Streptococcus pyogenes and Haemophilus 
influenzae. The common fungi causing dacryocystitis are Candida albicans, 
Aspergillus species[30]. 
 Syed Ali Raza Rizvi et al [31] in March 2015 studied 86 patients who 
presented with acute and chronic dacryocystitis. It included 23 male patients 
and 63 female patients. Ratio of male to female was 1:3.  Percentage of culture 
positivity was 76.47% in acute cases and 37.84% in chronic cases. In acute 
cases the predominant organism was Streptococcus pneumoniae (53.8%) 
followed by Staphylococcus aureus (46.1%). No gram negative bacteria were 
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isolated in acute cases. In chronic cases also the predominant organism was 
Streptococcus pneumoniae(35.7%) followed by Staphylococcus 
aureus(28.5%)and Pseudomonas aeruginosa(25%). 
JithendraKandati et al[5] in January  2015 studied 298 patients of 
dacryocystitis. It included 126 acute cases and 172 chronic cases. In both acute 
and chronic cases, females were more affected than males. Bacterial and fungal 
culture was performed in all the cases. Culture positivity was 85.57%. In two 
cases of chronic dacryocystitis, Candida albicans was isolated. Polymicrobial 
growth was exclusively present in chronic dacryocystitis. Overall, 
Staphylococcus aureus(24.5%) was the common gram positive bacteria 
isolated, followed by Staphylococcus epidermidis(20.3%) and Streptococcus 
pneumoniae(3.8%). Pseudomonas aeruginosa(21.3%) was the common gram 
negative bacteria isolated, followed by Escherichia coli(16.8%), Klebsiella 
pneumoniae (7%).   
IndrajitSarkar et al[32] in July 2015 studied 90 patients of dacryocystitis. 
It included 3 cases of congenital cases and 87 cases of chronic cases. Culture 
positivity was 83.33%. Single organism was isolated in 73.3% of samples, 
mixed organisms were isolated in 10% of samples.78.57%of isolates were 
Gram-positive bacteria and 21.43% of isolates were Gram-negative bacteria. 
The predominant organism isolated was Staphylococcus aureus(57.1%) 
followed by Streptococcus pneumoniae(14.2%), Pseudomonas 
aeruginosa(13%) and Klebsiella pneumoniae (7.1%). 
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 Shwetha B A et al[3] in 2014 studied 200 patients of chronic 
dacryocystitis. The percentage of culture positivity was 57.5%. The 
predominant organism isolated was Staphylococcus aureus(32.17%) followed 
by Klebsiella pneumoniae (14.78%),Streptococcus pneumoniae(11.3%), 
Staphylococcus epidermidis(8.69%) and  mixed growth (6.08%). 
 Bahram Eshraghi et al [33] in 2014 studied 100 patients of dacryocystitis 
which included 60 acute cases and 40 chronic cases. Overall culture positivity 
was 85%. Staphylococcus aureus was the predominant organism isolated from 
acute cases (35%) followed by Streptococcus viridans (17%), Klebsiella 
species(8%), Citrobacter species(8%), Pseudomonas aeruginosa(4%), 
Escherichia coli(4%),Staphylococcus epidermidis(4%) and Aspergillus 
species(2%).In chronic cases Staphylococcus epidermidis (38%) was the 
predominant organism isolated, followed by Streptococcus viridans(20%), 
Klebsiella species(10%) and Staphylococcus aureus(10%). 
 Khevna Patel et al [2] in 2014 studied 100 patients of chronic 
dacryocystitis which included 52 female patients and 48 male patients. Culture 
positivity was seen in 83% of samples. The predominant organism isolated was 
Staphylococcus aureus(41%) followed by Escherichia coli(17%), 
Pseudomonas aeruginosa(12%), Streptococcus pneumoniae(9%) and 
Klebsiella pneumoniae(3%). 
 Pradeep A.V et al[34] in 2013 studied 44 patients of chronic 
dacryocystitis. Lacrimal sac contents obtained during external 
dacryocystorhinostomy procedure were processed. A total of 21 organisms 
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were isolated from 44 specimens. The predominant isolate was Coagulase 
negative Staphylococci(71%), followed by Staphylococcus aureus (14%), 
Escherichia coli(4.7%) and Citrobacter freundii(4.7%).  
 Prakash R et al[35]in 2012 studied 80 patients of dacryocystitis which 
included both congenital and acquired cases. Females (70%) were more 
affected than males(30%).  Staphylococcus aureus (29.76%) was the common 
organism isolated in acquired cases, followed by Streptococcus 
pneumoniae(20.23%), Pseudomonas aeuginosa(14.28%), Klebsiella 
pneumoniae(8.33%) and Staphylococcus epidermidis(8.33%). Streptococcus 
pneumoniae(50%) was the common organism isolated in congenital cases, 
followed by Pseudomonas aeruginosa(20%) and Staphylococcus aureus(10%). 
 Shah C P et al[36] in 2011 studied 100 cases of dacryocystitis, which 
included 45 acute cases and 55 chronic cases. Culture positivity was 100%. 
Mixed cultures were isolated in 9.1% of samples. Escherichia coli was the 
predominant organism isolated from acute cases (22.9%) followed by 
Staphylococcus aureus(18.75%), Pseudomonas aeruginosa(18.75%), 
Coagulase negative Staphylococci(16.6%), Streptococcus species(12.5%) and 
Klebsiella species(10.4%). Staphylococcus aureus was the predominant 
organism isolated from chronic cases (27%) followed by, Pseudomonas 
aeruginosa(21.6%), Klebsiella species(14.8%), Coagulase negative 
Staphylococci(12.1%), Streptococci species(12.1%) and Escherichia 
coli(12.1%). 
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Chaudhary M et al [37] in 2010 studied 120 patients of chronic 
dacryocystitis. Culture positivity was 76.66%. Single organism was isolated in 
85.86% and mixed growth was present in 14.13% of culture positive cases. The 
predominant organism isolated was Coagulase Negative 
Staphylococci(33.96%) followed by, Staphylococcus aureus(25.46%) and 
Streptococcus pneumoniae(19.81%). Escherichia coli(5.66%) was the common 
gram negative organism isolated.  
Bharathi M J et al[38] in 2008 studied 1891 patients of dacryocystitis, 
which included 566 patients of acute dacryocystitis, and 1325 patients of 
chronic dacryocystitis. Culture was positive from 80.3% of the samples. The 
percentage of culture positivity was 90% in chronic dacryocystitis and 57.4% 
in acute dacryocystitis. In acute dacryocystitis the predominant organism was 
Staphylococcus aureus(22.3%) followed by Pseudomonas aeruginosa(21.1%). 
In chronic dacryocystitis the predominant organism was Coagulase negative 
Staphylococci(44.2%) followed by Staphylococcus aureus(10.8%) and 
Streptococcus pneumoniae(10%). 
 Mandal R et al [39] in 2008 studied 56 patients of chronic dacryocystitis 
who underwent either dacryocystectomy or dacryocystorhinostomy. Part of the 
sac was collected as samples. Culture positivity was 53.6%. Staphylococcus 
aureus(40%) was the common gram positive organism isolated, followed by 
Staphylococcus epidermidis(10%) and Streptococcus pneumoniae(10%). 
Pseudomonas aeruginosa (16.6%) was the common gram negative organism 
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isolated, followed by Klebsiella pneumoniae(6.6%) and Haemophilus 
influenzae (6.6%). 
BhavnaRaina et al [40] in 2010 studied 30 cases of congenital 
dacryocystitis. Culture positivity was 72.9%. Majority of bacterial isolates were 
Gram positive cocci (56.7%). Streptococcus pneumoniae (27.9%) was the 
predominant organism isolated, followed by Staphylococcus aureus(16.2%) 
and Staphylococcus albus(10.8%). 
 Andreas Kuchar et al [41] in 2000 studied 47 cases of congenital 
dacryocystitis, which included 3 bilateral cases. Totally 50 samples were 
studied. Culture positivity was 72.64%. 20 samples had mixed growth. The 
most common organism isolated was Streptococcus pneumoniae(35.4%), 
followed by Haemophillus influenzae (19.6%), Pseudomonas 
aeruginosa(10.9%) and Streptococcus viridans(10.9%). 
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MATERIALS AND METHODS 
This study was carried out in the Institute of Microbiology, Madras 
Medical College, Chennai in association with Regional Institute of 
Ophthalmology and Government Ophthalmic Hospital, Chennai. A total of 100 
clinically diagnosed cases of dacryocystitis of all age groups attending 
outpatient department at the Regional Institute of Ophthalmology and 
Government Ophthalmic Hospital were included in the study. The patients 
were categorized as acute, chronic and congenital dacryocystitis based on the 
age of onset, symptoms and signs. 
ETHICAL CLEARANCE:  
Before the commencement of the study, approval was obtained from the 
Institutional Ethics Committee. Informed consent was obtained from all the 
patients who satisfied the inclusion criteria. 
STUDY DESIGN:  
Cross sectional study.  
STUDY PERIOD: 
October 2014 to August 2015 
INCLUSION CRITERIA: 
     Clinically diagnosed cases of dacryocystitis of all age groups were 
included in the study and categorised as follows. 
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 Patients presenting with pain, redness and swelling in the region of 
lacrimal sac were included as acute dacryocystitis. 
 Adult patients presenting with persistent epiphora for more than 3 weeks 
and regurgitation of serous, mucoid or mucopurulent material on 
pressure over the lacrimal sac area or on lacrimal syringing were 
included as chronic dacryocystitis.  
 Children presenting with persistent epiphora from the first week of birth 
and regurgitation of serous, mucoid or mucopurulent material on 
pressure over the lacrimal sac area or on lacrimal syringing were 
included as congenital dacryocystitis. 
EXCLUSION CRITERIA: 
 The patients with the above symptoms who had received either topical 
or systemic antibiotics for the past one week during their visit to the 
hospital were excluded from the study. 
 All cases of pseudo epiphora and epiphora caused by conditions other 
than nasolacrimal duct obstruction were excluded from the study. 
        The diagnosis of dacryocystitis when given by Ophthalmologist, then 
samples were collected with their help. 
SAMPLE COLLECTION: 
A salient history was obtained from the patients before the collection of 
samples. Under strict aseptic precautions, samples were collected in three 
sterile swabs. 
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SAMPLES: 
 Pus or mucopurulent discharge drained by incision and drainage was 
collected in cases of acute dacryocystitis. 
 Serous, mucoid or mucopurulent discharge obtained by syringing of the 
lacrimal sac was collected in cases of chronic dacryocystitis.  Lacrimal 
sac contents obtained during DCT or DCR were also collected in few 
cases. 
 Serous, mucoid or mucopurulent discharge obtained by syringing of the 
lacrimal sac or obtained on pressure over the lacrimal sac area was 
collected in cases of congenital dacryocystitis. Lacrimal sac contents 
obtained during DCR were also collected in some cases.  
TRANSPORTATION AND PROCESSING OF SAMPLES: 
The samples were transported to the laboratory immediately and 
processed. Of the three swabs collected, one swab was used for direct gram 
staining and KOH mount. The other swab was used for inoculation of bacterial 
culture. The last swab was used for inoculation of fungal culture. 
DIRECT EXAMINATION:  
Direct gram staining:  
The smear was prepared on a clean grease free glass slide. After air 
drying heat fixation was done. Gram staining was performed. The stained 
smear was screened for pus cells and bacteria, their gram reaction, 
31 
 
arrangement, morphology and presence of gram positive budding yeast cells if 
any. 
10% KOH wet mount:  
The sample was added to a drop of 10% KOH on a clean glass slide. A 
coverslip was placed over the drop and allowed to stand at room temperature 
for 10 minutes and examined under microscope using low power and high 
power objectives for the presence of fungal elements. 
BACTERIAL CULTURE: 
The next  swab was inoculated on to MacConkey agar plate, Blood agar 
plate and were incubated at 37ºC and on to chocolate agar plate and incubated 
at 5-10% CO2 atmosphere at 37ºC for 24 hours. 
After 24 hours of incubation the culture plates were observed for 
growth, morphology of colonies and were subjected to Gram staining. If Gram 
staining shows Gram positive cocci, catalase test, coagulase test and other 
standard biochemical reactions and tests[42, 43] were done. If Gram staining 
shows Gram negative bacilli, catalase test, oxidase test, motility by hanging 
drop method and other standard biochemical reactions and tests were done. 
If there was no growth at 24 hours, the plates were further incubated for 
another 24 hours. If no growth was observed after 48 hours of incubation the 
culture was considered as negative for aerobic bacterial growth. 
Bacterial cultures were considered significant, if  
 Growth in the media was consistent with findings of direct microscopy, 
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 Presence of confluent growth at the inoculation site, 
 Same growth of organism was demonstrated on all the inoculated 
culture media plates.  
IDENTIFICATION OF ISOLATES: 
 Beta hemolytic colonies and golden yellow pigment on blood agar, 
Gram positive cocci in clusters in Gram stain,   catalase test positive,  
slide coagulase test positive,  tube coagulase test positive,  urease test 
positive,  mannitol fermenting,  phosphatase producing, MR test positive 
and VP test positive isolates were identified as  Staphylococcus aureus. 
 White opaque colonies on blood agar, Gram positive cocci in clusters in 
Gram stain, catalase test positive, slide coagulase test negative, tube 
coagulase test negative, phosphatase producing, Novobiocin sensitive 
and Polymyxin B resistant isolates were identified as Staphylococcus 
epidermidis. 
 Alpha haemolytic colonies on blood agar, Gram positive flame shaped 
diplococci in Gram stain, catalase test negative, optochin sensitive, bile 
solubility test positive and inulin fermenting isolates were identified as 
Streptococcus pneumoniae. 
 Non-haemolytic tiny colonies on blood agar, Gram positive cocci in 
pairs and short chains in Gram stain,  catalase test negative, bile esculin 
test positive, arginine dihydrolase test positive,  heat tolerant (surviving 
at 60oC for 30 min), mannitol fermenting, arabinose non-fermenting 
isolates were identified as Enterococcus faecalis. 
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 Lactose fermenting mucoid colonies on MacConkey agar, short Gram 
negative bacilli in Gram stain, non-motile bacilli detected by hanging 
drop method, catalase test positive, oxidase test negative, nitrate 
reduction test positive, indole test negative, MR test negative, VP test 
positive, citrate utilization test positive, acid butt and acid slant with gas 
on TSI, lysine decarboxylase test positive, ornithine decarboxylase test 
negative, urease test positive isolates were identified as Klebsiella 
pneumoniae. 
 Lactose fermenting colonies on MacConkey agar, Gram negative bacilli 
in Gram stain, motile bacilli detected by hanging drop method, catalase 
test positive, oxidase test negative, nitrate reduction test positive, indole 
test positive, MR test positive, VP test negative, citrate utilization test 
negative, acid butt and acid slant with gas on TSI, lysine decarboxylase 
test positive,urease test negative isolates were identified as Escherichia 
coli. 
 Non-lactose fermenting colonies on MacConkey agar,  bluish green 
pigment producing colonies on nutrient agar, slender Gram negative 
bacilli in Gram stain, motile bacilli detected by hanging drop method, 
catalase test positive, oxidase test positive, oxidative reaction in Huge 
&Leifson O/F medium, nitrate reduction test positive,  MR test negative, 
VP test negative, alkaline butt and alkaline slant on TSI, arginine 
dihydrolase test positive and lysine decarboxylase test negative isolates 
were identified as Pseudomonas aeruginosa. 
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ANTIMICROBIAL SUSCEPTIBILITY TESTING:[44,46] 
All the bacterial isolates obtained were subjected to antimicrobial 
susceptibility testing by using Kirby-Bauer disc diffusion method. To know the 
efficacy, antibiotic discs were tested against standard American Type Culture 
Collection (ATCC) control strains, Staphylococcus aureus ATCC 25923, 
Pseudomonas aeruginosa ATCC 27853, Escherichia coli ATCC 25922 as a 
quality control laboratory procedure. 
Antimicrobial susceptibility testing by Kirby – Bauer Disc Diffusion 
method:  
 3- 5 well isolated colonies from an agar plate culture were touched by a 
sterile bacteriological loop and emulsified in 3-4ml of sterile peptone 
water. The bacterial suspension was matched to a 0.5 McFarland 
standards.  
 By using a sterile cotton swab, the suspension was streaked in three 
directions on to the surface of a Mueller Hinton Agar plate. Mueller 
Hinton Agar with 5% sheep blood was used for antibiotic sensitivity 
testing of Streptococcus pneumoniae.  
 With the lid in place, the inoculated agar surface was allowed to dry for 
3 to 5 minutes before placing the antibiotic discs.  
 By using sterile forceps, appropriate antibiotic discs were placed on the 
surface of the agar. Five discs were placed per 90 mm plate.  
      The plates were incubated overnight at 37oC. After overnight incubation, 
the diameter of zone of inhibition was measured and interpreted as sensitive or 
resistant according to the CLSI guidelines[44].  
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Panel of antibiotics used in antimicrobial susceptibility testing of Gram 
positive cocci. 
Antibiotic Disc content 
Gram positive 
cocci 
Diameter of zone of 
inhibition in mm[44] 
Sensitive Inter -mediate Resistant 
Penicillin 10 units Staphylococcus species ≥ 29 - ≤ 28 
Cefoxitin 30 µg 
Staphylococcus 
aureus ≥ 22 - ≤ 21 
CoNS ≥ 25 - ≤ 24 
Oxacillin 1 µg S.pneumoniae ≥20   
Amikacin 30 µg Staphylococcus species ≥ 17 15-16 ≤ 14 
Tobramycin 10 µg Staphylococcus species ≥15 13-14 ≤12 
Erythromycin 15 µg 
Staphylococcus 
species& 
Enterococcus 
species 
≥ 23 14-22 ≤13 
S.pneumoniae ≥ 21 16-20 ≤15 
Ciprofloxacin 5 µg 
Staphylococcus 
species& 
Enterococcus 
species 
≥ 21 16-20 ≤15 
Gatifloxacin 5 µg 
Staphylococcus 
species ≥ 23 20-22 ≤19 
S.pneumoniae ≥ 21 18-20 ≤17 
Trimethoprim- 
Sulfamethoxazole 
1.25/ 
23.75µg S.pneumoniae ≥ 19 16-18 ≤15 
Ampicillin 10 µg Enterococcus species ≥17 - ≤16 
Vancomycin 30 µg Enterococcus species ≥17 15-16 ≤14 
Tetracycline 30 µg 
Enterococcus 
species& 
Staphylococcus 
species 
≥ 19 15-18 ≤14 
S.pneumoniae ≥ 28 25-27 ≤24 
Chloramphenicol 30 µg 
Staphylococcus 
species& 
Enterococcus 
species 
≥ 18 13-17 ≤12 
S.pneumoniae ≥ 21 - ≤20 
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Panel of antibiotics used in antimicrobial susceptibility testing of Gram 
negative bacilli. 
Antibiotic Disc content 
Gram negative 
bacilli 
Diameter of zone of 
inhibition in mm[44] 
Sensitive Inter -mediate Resistant 
Amikacin 30 µg 
Enterobacteriaceae 
&Pseudomonas 
aeruginosa 
≥ 17 15-16 ≤ 14 
Gentamicin 10 µg 
Enterobacteriaceae 
&Pseudomonas 
aeruginosa 
≥15 13-14 ≤12 
Cefotaxime 30µg Enterobacteriaceae  ≥26 23-25 ≤22 
Ceftazidime 30µg 
Enterobacteriaceae 
 ≥21 18-20 ≤17 
Pseudomonas 
aeruginosa ≥18 15-17 ≤14 
Ciprofloxacin 5 µg 
Enterobacteriaceae 
&Pseudomonas 
aeruginosa 
≥ 21 16-20 ≤15 
Tobramycin 10 µg 
Enterobacteriaceae 
&Pseudomonas 
aeruginosa 
≥15 13-14 ≤12 
Gatifloxacin 5 µg Enterobacteriaceae  ≥18 15-17 ≤14 
Chloramphenicol 30 µg Enterobacteriaceae  ≥ 18 13-17 ≤12 
Piperacillin-
tazobactam 
100µg/
10 µg 
Pseudomonas 
aeruginosa ≥21 15-20 ≤14 
Tetracycline 30 µg Enterobacteriaceae  ≥15 12-14 ≤11 
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Detection of methicillin resistance in Staphylococcus aureus and 
Coagulase negative Staphylococci (CoNS) isolates by cefoxitin disc 
diffusion test [44]: 
All Staphylococcus aureus and Coagulase negative Staphylococci 
(CoNS) isolates were subjected to cefoxitin disc diffusion test. Cefoxitin is used 
as a surrogate marker for detection of mecA-mediated oxacillin resistance 
[44].The bacterial suspension of test isolates were matched to a 0.5 McFarland 
standards and lawn cultured on Mueller Hinton Agar plates separately.  
Cefoxitin (30µg) disc were placed on the surface of lawn culture of the isolates. 
The plates were incubated in ambient air at 35°C for 24 hours.  
 
Interpretation as per CLSI guidelines:  
For Staphylococcus aureus and Staphylococcus lugdunensis 
Zone of inhibition ≥22mm - Sensitive 
Zone of inhibition ≤21mm - Resistant 
For Coagulase negative Staphylococci except Staphylococcus lugdunensis 
Zone of inhibition ≥25mm - Sensitive 
Zone of inhibition ≤24mm - Resistant 
Quality control strain used - Staphylococcus aureus ATCC 25923. 
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Screening Test for Extended -Spectrum β-Lactamases (ESBLs) in 
Klebsiella pneumoniae and Escherichia coli isolates[44,45]. 
        All the Klebsiella pneumoniae and Escherichia coli isolates were 
subjected to initial screening test for Extended -Spectrum β-Lactamases by 
using Cefotaxime and Ceftazidime discs as per CLSI guidelines. The use of 
more than one antimicrobial agent for screening improves the sensitivity of 
ESBL detection [44]. 
Test method - Disk diffusion    
Procedure: 
       The bacterial suspension of test isolates were matched to a 0.5 McFarland 
standards and lawn cultured on Mueller Hinton Agar plates separately.  
Ceftazidime (30 µg) and Cefotaxime (30 µg) discs were placed on the surface 
of lawn culture of the isolates. The plates were incubated in ambient air at 37°C 
for 16-18 hours. 
Results: 
Ceftazidime zone ≤22 mm, Cefotaxime zone ≤27 mm may indicate 
ESBL production.  
 
 
 
  
39 
 
FUNGAL CULTURE: 
The last swab was inoculated on to two Sabourauds Dextrose Agar 
(SDA) slopes and incubated at 250C and 370C. The culture was examined daily 
for one week and then three times per week for the next three weeks.  If there is 
no growth at 4 weeks of incubation, the culture was considered as negative for 
fungal growth. 
IDENTIFICATION OF FUNGAL ISOLATES[47]: 
If growth was seen on SDA slope, the morphology of colonies was 
observed. If cream coloured pasty colonies were seen, Gram staining was 
performed. Presence of Gram positive ovoid budding yeast cells in Gram 
staining was suggestive of Candida species. The following tests were done. 
Germ tube test: 
0.5 ml of sterile serum was taken in a sterile test tube. With a sterile 
bacteriological loop, a colony of yeast was touched and emulsified in the 
serum. The tube was incubated at 37oC for 2 hours. After 2 hours, a drop of 
serum was transferred to a clean glass slide. A coverslip was put and examined 
under microscope using low power and high power objectives[47,48].  
Interpretation: 
The test was considered as positive if there is formation of germ tube 
and there is no constriction between the yeast cell and the germination tube. 
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Candida CHROM Agar: 
The yeast colonies were inoculated on to Candida CHROM Agar and 
incubated at 37oC. The plates were read after 48 hours and the colour of the 
colony was observed. 
Observation & Interpretation:  
Candida albicans  - Light green 
Candida dubliniensis - Dark green 
Candida glabrata  - Pink to Purple 
Candida krusei  - Pink 
Candida parapsilosis - Cream to pale pink   
Candida tropicalis  - Blue with pink hallow[49] 
   
Corn Meal Tween 80 Agar (Dalmau Plate Culture Technique)[48,49] 
 By using a straight wire an isolated colony from the primary culture 
media was taken and inoculated on to cornmeal agar plate by making 
three parallel lines. 
 A sterile cover slip was placed over the surface of the agar, covering the 
inoculated streaks in such a way that the streak project beyond the 
coverslip. 
 The plate was incubated at 25⁰C for 48 hours. 
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 After 48 hours, the edge of the coverslip was examined under low power 
objective and high power objective for the presence of pseudo hyphae, 
blastoconidia and chlamydospores.  
 
ANTIFUNGAL SUSCEPTIBILITY TESTING OF YEAST: 
 Disc Diffusion method 
 Broth Micro dilution Method 
 
Disc diffusion method[50]: 
This method was carried out following the M 44-A CLSI guidelines 
using fluconazole and voriconazole discs.  
Inoculum preparation and application of discs: 
 With a sterile bacteriological loop, 3- 5 yeast colonies were taken from 
the culture grown on SDA and emulsified in 5ml of sterile saline.  
 The yeast suspension was matched to a 0.5 McFarland standards.  
 By using a sterile cotton swab, the suspension was streaked in three 
directions on to the surface of a Mueller Hinton Agar plate 
supplemented with 2% glucose and 0.5 µg/ml methylene blue. 
 By using sterile forceps, fluconazole and voriconazole discs were placed 
on the surface of the agar.  
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The plates were incubated at 37oC. After 24 hours of incubation, the 
diameter of zone of inhibition was measured and interpreted as sensitive or 
resistant according to the CLSI guidelines44A. Quality control strain used-
ATCC Candida albicans 90028. 
Antifungal disc Disc content 
Diameter of zone of inhibition in mm 
 
Sensitive 
 
Susceptible 
Dose 
Dependent 
Resistant 
Fluconazole 25 µg ≥17 14-16 ≤13 
Voriconazole 1 µg ≥17 14-16 ≤13 
 
Broth micro dilution method[51] 
The test was performed as per the CLSI guidelines. Minimal Inhibitory 
Concentration of Fluconazole, Amphotericin B and Itraconazole were 
determined. Dimethyl sulfoxide (DMSO) was used as solvent. Media used was 
RPMI 1640.Preparation of inoculum and antifungal stock solution was done 
according to the CLSI guidelines. 
The concentrations of the drugs tested were, 
Amphotericin B      16 to 0.0313μg/ml 
Fluconazole             64 to 0.125 μg/ml 
Itraconazole             16 to 0.0313 μg/ml 
Quality control strain used-ATCC Candida albicans 90028. 
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Procedure: 
 The broth micro dilution test was performed by using sterile, 
disposable, multi well micro dilution plates (96U-shaped wells). 
 100μl of varying drug concentrations was dispensed in each row 
from 1 to 10. Then 100μl of test inoculum was dispensed from 
row 1 to 10. 
 Row 11 was the growth control well contains 100 μl of sterile, 
drug-free medium and was inoculated with 100 μl of the 
corresponding inoculum suspension. Row 12 was the drug 
control well contains 100 μl of drug and 100 μl of sterile, drug-
free medium.  
 The micro dilution plates were incubated at 350C for 48 hours. 
After 48 hours the micro dilution wells were observed with the 
aid of reading mirror. The growth in each well was compared 
with that of the growth control well. 
  For Amphotericin B, MIC was interpreted as the lowest 
concentration in which the well was clear. 
  For Fluconazole and Itraconazole, MIC was interpreted as the 
lowest concentration in which a prominent decrease in turbidity 
was observed. A prominent decrease in turbidity corresponds to 
approximately 50% inhibition in growth as determined 
spectrophotometrically.          
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Interpretive Guidelines for In Vitro Susceptibility Testing of Candida 
Species: 
Break points (μg/ml) for Candida species. 
Antifungal 
agent Susceptible 
Susceptible Dose 
Dependent Resistant 
Fluconazole ≤ 8 16-32 ≥64 
Itraconazole ≤ 0.125 0.25-0.5 ≥1 
Amphotericin B ≤ 1 - >1 
 
Statistical analysis: 
Statistical analysis was done by using Statistical Package for Social 
Sciences (SPSS) version 20.0. Pearson Chi-square(X2) statistics was carried 
out, P value <0.05 is considered as statistically significant. 
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RESULTS & ANALYSIS 
This study was carried out at the Institute of Microbiology, Madras 
Medical College, Chennai, in association with Regional Institute of 
Ophthalmology and Government Ophthalmic Hospital, Chennai. 100 clinically 
diagnosed patients of dacryocystitis of all age groups were studied from 
October 2014 to August 2015. 
Out of 100 patients, 98 patients had unilateral dacryocystitis and 2 
patients had bilateral dacryocystitis. Totally 102 samples were collected from 
100 patients. 
 
TABLE NO: 1. ANALYSIS OF AGE DISTRIBUTION OF 
DACRYOCYSTITIS CASES 
Age group in 
years 
 
 
Male 
 
Female 
Total 
No Percentage 
Below 10 7 5 12 12 % 
11-20 0 1 1 1 % 
21-30 0 2 2 2 % 
31-40 3 6 9 9 % 
41-50 4 23 27 27 % 
51-60 8 14 22 22 % 
61-70 7 11 18 18 % 
71-80 5 4 9 9 % 
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        This study shows highest number of acquired dacryocystitis cases among 
people in the age group of 41-50 years(27%) followed by 51-60 years 
(22%)and 61-70 years(18%). Overall the mean age is 47.97 years. The highest 
number of females were in the age group of 41-50 years and of males were in 
the age group of 51-60 years.  
 
Distribution of dacryocystitis cases according to age. 
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TABLE NO: 2. CLINICAL DIAGNOSIS OF DACRYOCYSTITIS AND 
THEIR DISTRIBUTION 
Clinical diagnosis of 
dacryocystitis 
Total no of 
cases Percentage 
 
 
P value<0.05 
Congenital dacryocystitis 12 12% 
Acute dacryocystitis 8 8% 
Chronic dacryocystitis 80 80% 
 
      From the above table it is observed that, in our study chronic dacryocystitis 
is more common than the congenital and acute dacryocystitis and it is 
statistically significant. 
Clinical diagnosis of dacryocystitis and their distribution 
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TABLE NO: 3. GENDER DISTRIBUTION OF DACRYOCYSTITIS 
CASES 
Total 
number 
of patients 
 
Male 
 
Female 
100 
No Percentage No Percentage 
34 34% 66 66% 
 
Gender distribution of dacryocystitis cases. 
 
 
 
 
 
 
 
 
 
Out of 100 cases under the study, it is observed that females (66%) were 
more affected than males (34%). The female: male ratio is 1.9:1 
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TABLE NO: 4. DISTRIBUTION OF DACRYOCYSTITIS CASES WITH 
RESPECT TO GENDER AND CLINICAL DIAGNOSIS.  
 
Gender 
No of cases 
 
Total  
 
P value 
>0.05 
Congenital 
dacryocystitis 
Acute 
dacryocystitis 
Chronic 
dacryocystitis 
Male 7 3 24 34 
Female 5 5 56 66 
Total 12 8 80 100 
 
Distribution of dacryocystitis cases with respect to gender and clinical 
diagnosis. 
 
 
 
 
 
 
 
 
The association between the gender and the clinical diagnosis of 
dacryocystitis was tested by using Chi square (χ2) test. The P value is >0.05. 
This denotes there is no significant correlation between the gender and the 
clinical type of dacryocystitis. 
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TABLE NO:5. DISTRIBUTION OF DACRYOCYSTITIS CASES 
ACCORDING TO THE EYE AFFECTED 
 
Side affected No of cases Percentage 
Left eye 63 63 
Right eye 35 35 
Bilateral 2 2 
Total 100 100 
 
Distribution of dacryocystitis cases according to the eye affected 
 
 
 
 
 
 
 
 
 
From these findings it is observed that in this study, left eye (63%) is 
more affected than the right eye (35%).  
2% of the cases were bilateral.  
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TABLENO:6. ANALYSIS OF DISTRIBUTION OF DACRYOCYSTITIS 
CASES ACCORDING TO GENDER AND EYE AFFECTED 
 
Gender Eye affected( No of cases) Total 
 
P value 
>0.05 
Left Right Bilateral 
Male 21 12 1 34 
Female 42 23 1 66 
Total 63 35 2 100 
 
 Distribution of dacryocystitis cases according to gender and eye affected 
 
 
 
 
 
 
 
 
 
The association between the gender and the eye affected was tested by 
using Chi square (χ2) test. The P value is >0.05. This denotes there is no 
significant correlation between the gender and the eye affected. 
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TABLE NO: 7. CULTURE POSITIVITY IN DACRYOCYSTITIS CASES 
Total no 
of cases 
Total no of 
samples Culture positive Culture negative 
 
100 
 
102 
Number Percentage Number Percentage 
53 51.9% 49 48.03% 
 
Percentage of culture positivity in dacryocystitis cases 
 
 
 
 
 
 
 
 
From the above findings it is observed that in this study the overall 
culture positivity among dacryocystitis cases was 51.9%. 
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TABLE NO: 8. ANALYSIS OF CULTURE POSITIVITY AMONG 
CONGENITAL, ACUTE AND CHRONIC DACRYOCYSTITIS CASES 
 
Clinical type 
Total 
no of 
cases 
Total 
no of 
samples 
Culture positive Culture negative 
Number Percentage Number Percentage 
Congenital 
dacryocystitis 12 12 7 58.3% 5 41.6% 
Acute 
dacryocystitis 8 8 6 75% 2 25% 
Chronic 
dacryocystitis 80 82 40 48.7% 42 51.2% 
 
Analysis of culture positivity among congenital, acute and chronic 
dacryocystitis cases 
 
 
 
From these findings it is observed that culture positivity was high in 
acute dacryocystitis (75%) followed by congenital dacryocystitis (58.3%) and 
chronic dacryocystitis (48.7%). 
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TABLE NO: 9. DISTRIBUTION OF SINGLE AND MIXED GROWTH 
ISOLATED FROM DACRYOCYSTITIS CASES  
Total no of 
culture positive 
samples 
 
Single/Mixed 
growth 
 
No. of 
samples 
 
Percentage 
 
P value 
<0.05 
 
53 
Single organism 48 90.5% 
Mixed organisms 5 9.4% 
 
 Distribution of single and mixed growth isolated from dacryocystitis cases 
 
 
 
 
 
 
 
 
In this study, out of 53 total culture positive samples, 90.5% yielded 
single organism and 9.4% yielded mixed organisms. It is statistically 
significant (P value <0.05). 
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TABLE NO: 10.   DISTRIBUTION OF SINGLE AND MIXED GROWTH 
AMONG CONGENITAL, ACUTE AND CHRONIC DACRYOCYSTITIS 
CASES 
Single/Mixed 
growth 
No of culture positive samples 
  
Total 
Congenital 
dacryocystitis 
Acute 
dacryocystitis 
Chronic 
dacryocystitis 
Single growth 7 6 35 48 
Mixed growth - - 5 5 
Total 7 6 40 53 
 
Distribution of single and mixed growth among congenital, acute and 
chronic dacryocystitis cases 
 
 
 
 
 
 
 
From the above findings it is observed that in this study mixed growth 
was present in chronic dacryocystitis cases only.  
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TABLE NO: 11. DISTRIBUTION OF MIXED ISOLATES 
Organisms No of cases 
Staphylococcus aureus + Candida albicans 1 
Escherichia coli + Staphylococcus epidermidis 1 
Klebsiella pneumoniae + Staphylococcus epidermidis 1 
Klebsiella pneumoniae + Staphylococcus aureus 1 
Pseudomonas aeruginosa + Staphylococcus epidermidis 1 
 
From the above findings, it is observed that, among 5 mixed isolates, 
mixed bacterial growth was present in 4 cases and mixed bacterial and fungal 
growth was present in 1 case. 
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TABLE NO: 12. DISTRIBUTION OF BACTERIAL AND FUNGAL 
ISOLATES AMONG DACRYOCYSTITIS CASES. 
 
Type of 
growth 
No of isolates 
 
 
Total no 
of 
isolates 
 
Percentage  
 
P 
value<0.05 
Single 
growth 
Mixed 
growth 
Bacterial 47 9 56 96.5% 
Fungal 1 1 2 3.4% 
Total 48 10 58 100% 
 
Distribution of bacterial and fungal isolates among dacryocystitis cases. 
 
 
 
 
 
 
 
 
 
From the above findings it is observed that in this study bacterial growth 
was predominant and it is statistically significant (P value <0.05). 
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TAB NO: 13. DISTRIBUTION OF GRAM POSITIVE & GRAM 
NEGATIVE BACTERIA AND FUNGAL ISOLATES AMONG 
CONGENITAL, ACUTE AND CHRONIC DACRYOCYSTITIS CASES 
 
Microorganism 
Number of isolates 
  
Total 
 
Percentage Congenital 
dacryocystitis 
Acute 
dacryocystitis 
Chronic 
dacryocystitis 
Gram positive 
bacteria 6 5 23 34 58.6% 
Gram negative 
bacteria 1 1 20 22 37.9% 
Fungal 
isolates - - 2 2 3.4% 
Total 7 6 45 58 100% 
 
Distribution of Gram positive &Gram negative bacteria and fungal 
isolates among congenital, acute and chronic dacryocystitis cases 
 
 
 
 
 
 
 
 
From the above findings it is observed that Gram positive bacteria were 
the predominant isolates in all the clinical types of dacryocystitis. Fungi were 
isolated only from chronic cases. 
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TABLE NO:14. DISTRIBUTION OF BACTERIAL ISOLATES IN 
CONGENITAL DACRYOCYSTITIS CASES. 
Total no of 
cases/samples 
No of 
organisms 
isolated 
Organism No of isolates Percentage 
12 7 
Staphylococcus 
aureus 2 28.5% 
Staphylococcus 
epidermidis 1 14.2% 
Streptococcus 
pneumoniae 3 42.8% 
Pseudomonas 
aeruginosa 1 14.2% 
 
Distribution of bacterial isolates in congenital dacryocystitis cases. 
 
 
 
 
 
 
 
 
From the above findings it is observed that in this study, the 
predominant organism isolated from congenital dacryocystitis cases is 
Streptococcus pneumoniae.  
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TABLE NO: 15. DISTRIBUTION OF BACTERIAL ISOLATES IN 
ACUTE DACRYOCYSTITIS CASES. 
Total no 
of cases/ 
samples 
No of organisms 
isolated 
 
Organism 
 
No of 
isolates 
 
Percentage 
8 6 
Staphylococcus 
aureus 3 50% 
Staphylococcus 
epidermidis 2 33.3% 
Escherichia coli 1 16.6% 
 
Distribution of bacterial isolates in acute dacryocystitis cases. 
 
 
 
 
 
 
 
 
 
From the above findings it is observed that in this study, the 
predominant organism isolated from acute dacryocystitis cases is 
Staphylococcus aureus.  
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TABLE NO: 16. DISTRIBUTION OF BACTERIAL AND FUNGAL 
ISOLATES IN CHRONIC DACRYOCYSTITIS CASES. 
 
Total no 
of cases 
Total 
no of 
samples 
No of 
organisms 
isolated 
 
Organism 
 
No of 
isolates 
 
Percentage 
80 
 
(78 
unilateral 
& 
2 
bilateral 
cases) 
82 45 
Staphylococcus 
aureus 11 24.4% 
Staphylococcus 
epidermidis 7 15.5% 
Streptococcus 
pneumoniae 3 6.6% 
Enterococcus 
faecalis 2 4.4% 
Klebsiella 
pneumoniae 9 20% 
Escherichia coli 
 6 13.3% 
Pseudomonas 
aeruginosa 5 11.1% 
Candida albicans 
 2 4.4% 
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Distribution of bacterial and fungal isolates in chronic dacryocystitis cases. 
 
 
 
 
 
 
 
 
 
 
From the above findings it is observed that in this study Staphylococcus 
aureus (24.4%) was the predominant organismwg isolated from chronic 
dacryocystitis cases. Klebsiella pneumoniae (20%) was the common Gram 
negative bacteria isolated. Candida albicans was isolated from 2 cases of 
chronic dacryocystitis. 
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TABLE NO: 17.ANTIBIOTIC SENSITIVITY PATTERN OF GRAM 
POSITIVE BACTERIAL ISOLATES 
 
Antibiotic 
Staphylococcus 
aureus 
(n = 16) 
Staphylococcus 
epidermidis(n 
= 10) 
Streptococcus 
pneumoniae    
(n = 6) 
Enterococcus 
faecalis(n = 2) 
S % S % S % S % 
Cefoxitin 16 100 10 100 - - - - 
Penicillin 9 56.2 7 70 - - - - 
Erythromycin 10 62.5 8 80 4 66.6 2 100 
Ciprofloxacin 5 31.2 6 60 - - 1 50 
Gatifloxacin 15 93.7 10 100 6 100 - - 
Amikacin 10 62.5 7 70 - - - - 
Tobramycin 11 68.7 9 90 - - - - 
Oxacillin - - - - 6 100 - - 
TMP-SMX - - - - 2 33.3 - - 
Ampicillin - - - - - - 1 50 
Vancomycin - - - - - - 2 100 
Tetracycline 13 81.2 10 100 6 100 2 100 
Chloramphenicol 14 87.5 10 100 6 100 2 100 
 
TMP-SMX -Trimethoprim- Sulfamethoxazole; S- sensitive 
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Antibiotics
Staphylococcus aureus
Staphylococcus epidermidis
Streptococcus pneumoniae    
Enterococcus faecalis
Antibiotic sensitivity pattern of gram positive bacterial isolates 
 
It is observed that in our study, Gatifloxacin was the highly sensitive 
antibiotic against all Gram positive bacteria tested. Ciprofloxacin and 
Trimethoprim- Sulfamethoxazole were the least sensitive antibiotics against the 
Gram positive bacteria tested. 
 In our study, Methicillin resistance was not detected among 
Staphylococci isolates. 
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TABLE NO:  18. ANTIBIOTIC SENSITIVITY PATTERN OF GRAM 
NEGATIVE BACTERIAL ISOLATES 
 
PT-Piperacillin-tazobactam ;  S- sensitive 
 
 
 
Antibiotic 
Klebsiella 
pneumoniae 
(n = 9) 
Escherichia 
coli 
(n = 7) 
Pseudomonas 
aeruginosa 
(n = 6) 
S % S % S % 
Amikacin 6 66.6 5 71.4 5 83.3 
Gentamicin 5 55.5 3 42.8 3 50 
Tobramycin 9 100 7 100 6 100 
Cefotaxime 9 100 7 100 - - 
Ceftazidime 9 100 7 100 6 100 
Ciprofloxacin 4 44.4 2 28.5 2 33.3 
Gatifloxacin 8 88.8 6 85.7 - - 
PT - - - - 6 100 
Tetracycline 7 77.7 6 85.7 - - 
Chloramphenicol 8 88.8 7 100 - - 
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Antibiotic sensitivity pattern of gram negative bacterial isolates 
 
 
 
 
 
 
 
 
 
Antibiotic sensitivity pattern showed, all Gram negative bacteria were 
highly sensitive to Tobramycin. The least sensitive antibiotics against all Gram 
negative organisms were, Ciprofloxacin and Gentamicin. 
       In our study, ESBL production was not detected among Escherichia coli 
and Klebsiella pneumoniae isolates. 
ANTIFUNGAL SUSCEPTIBILITY PATTERN OF FUNGAL ISOLATES 
In our study two Candida albicans were isolated from chronic 
dacryocystitis cases. Both were sensitive to the tested antifungal drugs -
Amphotericin B, Fluconazole, Voriconazole and Itraconazole. 
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                                DISCUSSION 
Dacryocystitis is one of the most common infections of the eye. It can 
be congenital or acquired. Congenital dacryocystitis affects both sexes equally. 
Acquired dacryocystitis is common in females[15]. There are multiple factors 
which play a role in acquiring infection of the lacrimal drainage system. The 
nasolacrimal system is lined by mucus lined tract contiguous with conjunctiva 
and nasal mucosa that are normally colonised with bacteria. 
Lacrimal apparatus is concerned with secretion and draining of tears, 
which keep the cornea moist and also protects against airborne pathogens and 
foreign bodies [34]. Obstruction of the nasolacrimal duct results in stasis of 
tears, desquamated cells and mucous secretions above the level of obstruction 
which creates a fertile environment for secondary bacterial infection [5]. Both 
acute dacryocystitis and chronic dacryocystitis pose a constant threat to cornea 
and orbital soft tissue. Dacryocystitis is mostly caused by bacteria. Fungal 
infections caused by Candida albicans and Aspergillus species occur 
infrequently[31]. The bacterial agents of dacryocystitis are variable in 
congenital, acute or chronic cases. However pathogens implicated in 
dacryocystitis are variable from place to place depending upon the local 
climate conditions. So it is very important to know the pathogens region wise 
in management of this condition. Our study was performed to know the 
bacterial and fungal aetiology of congenital, acute and chronic dacryocystitis 
and their in vitro antibiotic susceptibility pattern and antifungal susceptibility 
pattern. 
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AGE DISTRIBUTION: 
Dacryocystitis generally affects two age groups, infants and adult 
females over 40 years of age [1]. In our study acquired dacryocystitis was 
common in the age group of 41-50 years. The mean age for dacryocystitis is 
47.97 years (Table 1).  
This finding is in concordance with study done by Suharshi Gupta et al 
in which acquired dacryocystitis was common in the age group of 41-50 
years[52]. 
Similarly JyotiBhuyan et al [53] and Shah CP et al [36]in their study found 
that chronic dacryocystitis was more common in the age group of 41-50 years.   
The mean age for acquired dacryocystitis was 49.82 years in the study 
done by IndrajitSarkar et al[32].    
CLINICAL TYPE: 
In our study chronic dacryocystitis (80%) was more common than acute 
one (8%).  Congenital dacryocystitis accounts for 12% of cases (Table 2).  
This finding correlates with study done by Bharathi et al [38] in which 
70.1% had chronic onset and 29.9% patients had acute onset dacryocystitis. 
Similarly Syed Ali RazaRizvi et al[31] reported 81.3% of chronic dacryocystitis 
and 18.7% of acute dacryocystitis.   
Prakash et al[35] studied congenital and acquired dacryocystitis cases and 
reported 63.75% cases of chronic dacryocystitis, 25% cases of acute 
dacryocystitis and 11.25% cases of congenital dacryocystitis.  
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Acute dacryocystitis invariably led to chronic dacryocystitis, so chronic 
form is more common. 
GENDER DISTRIBUTION: 
In our study females (66%) were more affected than males (34%), the 
ratio being 1.9:1 (female: male). (Table 3&4) 
This finding correlates with study done by Delia A Ch et al [54] in which 
among 421 cases of chronic dacryocystitis, 61.04% were females and 38.95% 
were males. Chaudhry IA et al [55] reported in their study that females (65.4%) 
were more affected than males (34.6%).  
Similarly Sarkar I et al[32] in their study reported a female to male ratio 
of 2.1:1  and Badhu B et al[56]reported female to male ratio of 2:1. 
The female predilection may be due to presence of narrow nasolacrimal 
duct in females, usage of kajal by females and hormonal factors [35, 57]. 
LATERALITY: 
In our study left eye (63%) was more commonly affected than the right 
eye (35%) and 2% of cases were bilateral (Table 5&6).  
This finding correlates with the study done by Khevna Patel et al[2] in 
which  dacryocystitis was more common in the left eye (56%) than the right 
eye(44%). Prakash R et al[35] found in their study that there was higher 
incidence of dacryocystitis on left side (50%) as compared to right side(40%) 
and 10% of the cases were bilateral. 
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The predilection of the left side is possibly because the nasolacrimal 
duct and the lacrimal fossa form a wider angle on the right side than on the left 
side [14].  
CULTURE POSITIVITY: 
In our study, the overall culture positivity was 51.9 % (Table7). Culture 
positivity in acute, chronic and congenital dacryocystitis cases were 75%, 48.7% 
and 58.3% respectively (Table 8). 
This finding correlates with study done by Syed Ali RazaRizvi et al[31] 
in which the percentage of culture positivity was 76.47% in acute cases and 
37.84% in chronic cases. 
Madhusudhan et al [58] studied 23 patients of acute dacryocystitis and 
culture positivity was 69.5%. Shwetha B A et al[3]  studied 200 patients of 
chronic dacryocystitis. The percentage of culture positivity was 57.5%.  
Andreas Kuchar et al[41] studied 47 cases of congenital dacryocystitis 
and culture positivity was 72.64%.  
NUMBER OF ORGANISMS: 
In our study, single organism was isolated from 90.5% of culture 
positive cases. Mixed organisms were isolated from 9.4% of culture positive 
cases (Table 9). All the mixed isolates were from chronic dacryocystitis 
cases(Table 10).The mixed growth was predominantly bacterial isolates 
(Table11). 
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This finding correlates with the study done by Shah C P et al [36] in 
which single organism was isolated from 90.9%  and  mixed growth was 
isolated from 9.1% of culture positive cases. Similarly, Bharathi et al [38] 
reported 93.8% of single organism and 6.2% of mixed isolates. 
A higher incidence of mixed isolates was reported by Chaudhary M et al 
[37] (14.1%), JithendraKandati et al[5] (14.5%). 
BACTERIAL AND FUNGAL PROFILE OF DACRYOCYSTITIS 
The spectrum of microorganisms causing dacryocystitis may vary from 
region to region.  
In our study, bacterial growth (96.5%) was more common than fungal 
growth (3.4%) (Table 12). 
Similarly, Jithendra Kandati et al [5] and Bahram Eshraghi et al [33] 
reported in their study that bacterial growth was common than fungal growth in 
dacryocystitis cases. 
In our study, Gram positive bacteria predominate in congenital, acute 
and chronic dacryocystitis cases. Overall Gram positive bacteria, Gram 
negative bacteria and fungal isolates account for 58.6%, 37.9% and 3.4% of 
culture positives respectively. The fungal growth was present only in chronic 
cases (Table 13). 
This finding coincides with the following studies. Kebede et al [59] 
reported 62.6% of Gram positive bacteria and 37.4% of Gram negative bacteria. 
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Similarly Prakash et al[35] reported 64.8% of Gram positive bacteria and 35.11% 
of Gram negative bacteria. 
Mills et al[60] reported 68.8% of Gram positive bacteria and 28.7% of 
Gram negative bacteria. A higher incidence of Gram positive bacteria of 69% 
and 78.57% was reported by Hartikainen J et al[61] and IndrajitSarkar et 
al[32]respectively. 
Congenital dacryocystitis: 
In our study, Streptococcus pneumoniae (42.8%) was the common 
organism isolated from congenital dacryocystitis cases, followed by 
Staphylococcus aureus(28.5%), Staphylococcus epidermidis(14.2%) and 
Pseudomonas aeruginosa(14.2%)(Table 14). 
This finding correlates with the study done by, Andreas Kuchar et al[41] 
who studied 47 cases of congenital dacryocystitis and the most common 
organism isolated was Streptococcus pneumoniae(35.4%).  
Similarly, UmeshBareja et al[62] and Usha K et al[63]reported 
Streptococcus pneumoniae as the most common organism isolated from 
congenital dacryocystitis cases.  
Acute dacryocystitis:  
In our study, Staphylococcus aureus(50%) was the most common 
organism isolated from acute cases, followed by Staphylococcus 
epidermidis(33.3%) and Escherichia coli(16.6%)(Table 15). 
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This finding correlates with the study done by BahramEshraghi et al[33] 
in which  Staphylococcus aureus was the predominant organism isolated from 
acute dacryocystitis cases (35%). 
Similarly, Bharathi et al[38] and Ali MJ et al [64]  reported in their study 
that Staphylococcus aureus was the predominant organism in acute 
dacryocystitis cases. 
Chronic dacryocystitis:          
In our study, Staphylococcus aureus(24.4%) was the predominant 
organism isolated from chronic cases, followed by Klebsiella pneumoniae 
(20%), Staphylococcus epidermidis(15.5%), Escherichia coli (13.3%), 
Pseudomonas aeruginosa(11.1%),  Streptococcus pneumoniae (6.6%), 
Enterococcus faecalis(4.4%)and Candida albicans(4.4%) (Table 16). 
This finding correlates with the study done by Shah C P et al [36] in 
which Staphylococcus aureus(27%) was the predominant organism isolated 
from chronic cases. Similarly, Shwetha B A et al[3] reported Staphylococcus 
aureus(32.1%) as the predominant organism isolated from chronic cases. 
Sun X et al[65] and Mandal et al[39]also reported Staphylococcus aureus 
as the common organism in chronic dacryocystitis cases accounting for 34.5% 
and  40% respectively. 
However in studies done by BahramEshraghi et al[33] and Razavi et al[66], 
Staphylococcus epidermidis was the predominant organism in chronic 
dacryocystitis cases. 
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In our study Enterococcus faecalis(4.4%) was isolated in chronic cases. 
Similarly, Briscoe D et al [67] and Indrajit Sarkar et al [32] reported 7% and 1.1% 
of Enterococcus species respectively. 
Klebsiella pneumoniae was the predominant Gram negative bacteria 
isolated in our study. Similarly Shwetha B A et al[3],  Bahram Eshraghi et 
al[33]reported Klebsiella pneumoniae as common Gram negative bacteria in 
chronic cases.  
However Assefa Y et al[68], Shah CP et al[36] , Mandal et al[39] and 
JyotiBhuyan et al[53] reported Pseudomonas aeruginosa as common Gram 
negative bacteria in chronic cases. 
In our study, Candida albicans was isolated from two cases of chronic 
dacryocystitis. Similarly Brook et al [69] reported 5% of fungal isolates in 
dacryocystitis cases, of which 3.3% was Candida albicans. Jithendra Kandati et 
al [5] reported 0.6% of Candida albicans out of 314 isolates.  
Obi et al [70] reported a case of dacryocystitis caused by Candida 
dubliniensis in a neutropenic patient.  
BahramEshraghi et al [33]in their study reported 2% of Aspergillus 
species in dacryocystitis cases. 
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ANTIBIOTIC SENSITIVITY PATTERN 
Gram positive bacteria (Table 17): 
In our study, Gatifloxacin was the highly sensitive antibiotic against all 
Gram positive bacteria tested. Ciprofloxacin and Trimethoprim- 
Sulfamethoxazole were the least sensitive antibiotics against Gram positive 
bacteria tested.  
Similarly IndrajitSarkar et al[32] and Bharathi et al[38] reported  
Gatifloxacin as the highly sensitive antibiotic against Gram positive bacteria. 
           Assefa Y et al [68] and Bharathi et al [38] in their study reported 
ciprofloxacin as least sensitive antibiotic against Gram positive bacteria.  
In our study Methicillin resistance was not detected among 
Staphylococci isolates. 
Gram negative bacteria (Table 18): 
In our study, all Gram negative bacteria were highly sensitive to 
Tobramycin. All Klebsiella pneumoniae and Escherichia coli isolates were 
100% sensitive to Cefotaxime and Ceftazidime. All Pseudomonas aeruginosa 
isolates were 100% sensitive to Ceftazidime and Piperacillin-tazobactam.  The 
least sensitive antibiotics against all Gram negative bacteria were, 
Ciprofloxacin and Gentamicin. 
Similarly Suharshi Gupta et al [52] and JithendraKandati et al [5] reported 
Tobramycin as most effective antibiotic against Gram negative bacteria. 
76 
 
Bharathi et al[38] and Prakash R et al[35] reported Ciprofloxacin as least 
effective antibiotic against Gram negative bacteria. 
The reason for resistance to Ciprofloxacin and Gentamicin might be due 
to routine use of these antibiotics for all ocular infections in our population. 
In our study, ESBL production was not detected among Escherichia coli 
and Klebsiella pneumoniae isolates.      
ANTIFUNGAL SUSCEPTIBILITY PATTERN:  
In our study both the Candida albicans isolates were sensitive to the 
tested antifungal drugs -Amphotericin B, Fluconazole, Voriconazole and 
Itraconazole. 
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SUMMARY 
 The present study was carried out at the Institute of Microbiology, 
Madras Medical College, Chennai, in association with Regional Institute 
of Ophthalmology and Government Ophthalmic Hospital, Chennai.  
 100 clinically diagnosed patients of dacryocystitis of all age groups were 
studied from October 2014 to August 2015. 
 12 patients of congenital dacryocystitis, 8 patients of acute 
dacryocystitis and 80 patients of chronic dacryocystitis were studied. 
 Dacryocystitis was more common in the age group of 40 to 50 years. 
 Females (66%) were more affected than males (34%). 
 Out of 100 patients, 98 patients had unilateral dacryocystitis and 2 
patients had bilateral dacryocystitis. Totally 102 samples were collected 
from 100 patients. 
 Left eye (63%) was commonly affected than the right eye (35%). 
 51.9% of samples were culture positive, 48.03% of samples were culture 
negative. 
 The highest culture positivity was found in acute dacryocystitis (75%) 
followed by congenital dacryocystitis (58.3%) and chronic 
dacryocystitis (48.7%). 
 Among the culture positive samples, 90.5% yielded single organism and 
9.4% yielded mixed organisms. 
78 
 
 Mixed organisms were isolated only from chronic dacryocystitis cases. 
 Totally, 58 organisms were isolated from 102 samples. 
 Among the 58 organisms isolated, 58.6% were Gram positive bacteria, 
37.9% were Gram negative bacteria, and 3.4% were fungal isolates. 
 Fungal organisms were isolated only from chronic dacryocystitis cases. 
 Streptococcus pneumoniae (42.8%) was the common organism isolated 
from congenital dacryocystitis cases, followed by Staphylococcus 
aureus, Staphylococcus epidermidis and Pseudomonas aeruginosa. 
 Staphylococcus aureus (50%) was the most common organism isolated 
from acute dacryocystitis cases, followed by Staphylococcus 
epidermidis and Escherichia coli. 
 Staphylococcus aureus(24.4%) was the common organism isolated from 
chronic dacryocystitis cases, followed by Klebsiella pneumoniae, 
Staphylococcus epidermidis, Escherichia coli, Pseudomonas 
aeruginosa, Streptococcus pneumoniae, Enterococcus faecalis and 
Candida albicans.  
 All the Staphylococci isolates were Methicillin sensitive. 
 All Gram positive bacteria were highly sensitive to Gatifloxacin and 
least sensitive to Ciprofloxacin.  
 ESBL production was not detected among Escherichia coli and 
Klebsiella pneumoniae isolates. 
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 All Gram negative bacteria were highly sensitive to Tobramycin and 
least sensitive to Ciprofloxacin and Gentamicin.  
 The two Candida albicans isolates were sensitive to Amphotericin B, 
Fluconazole, Voriconazole and Itraconazole. 
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CONCLUSION 
This cross sectional study conducted at the Institute of Microbiology, 
Rajiv Gandhi Government General Hospital aimed at isolating the bacteria and 
fungi associated with congenital, acute and chronic dacryocystitis and had 
revealed that Gram positive bacteria were predominant in all the three types of 
dacryocystitis cases. Streptococcus pneumoniae was the common pathogen in 
congenital dacryocystitis and Staphylococcus aureus was the common 
pathogen in acute and chronic dacryocystitis. The incidence of Gram negative 
pathogens were more in chronic dacryocystitis. Klebsiella pneumoniae was the 
common Gram negative pathogen isolated from chronic cases. Candida 
albicans was isolated from two cases of chronic dacryocystitis. 
Dacryocystitis pose a constant threat to cornea and orbital soft tissue. 
There is a change in etiological agents causing dacryocystitis over the time.  
Microbial culture and sensitivity when performed in samples from all 
the patients having dacryocystitis is useful. This would contribute to the choice 
of appropriate and effective antimicrobial agents.  
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APPENDIX – I 
 
ABBREVIATIONS 
ATCC  - American type culture collection 
CLSI  - Clinical and Laboratory Standards Institute 
DCR  - Dacryocystorhinostomy 
DCT  - Dacryocystectomy 
ESBL  - Extended spectrum beta lactamases 
KOH  - Potassium hydroxide 
MR  - Methyl red 
MIC  - Minimal inhibitory concentration 
NLD  - Nasolacrimal duct 
RPMI  - Rosewell Park Memorial Institute 
SDA  - Sabourauds Dextrose Agar 
TSI  - Triple Sugar Iron 
VP  - Voges -Proskauer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX  II 
 
A.STAINS AND REAGENTS 
 
I. Gram staining 
Methyl violet (2%)   l0g Methyl violet in l00ml 
absolute alcohol in 1litre of 
distilled water (primary stain) 
Grams Iodine   l0g Iodine in 20g KI 
(fixative) 
Acetone    Decolourising agent 
Carbolfuchsin 1%   Secondary stain 
II. 10% KOH 
Potassium hydroxide  l0g 
Glycerol    l0ml 
Distilled water   80ml 
 
 
B.MEDIA USED: 
 
1.MacConkey agar 
Peptone    20g 
Sodium taurocholate  5g 
Distilled Water   1 ltr 
Agar     20g 
2% neutral red in 50% ethanol 3.5ml 
10% lactose solution  l00mI  
 
 
Dissolve peptone and taurocholate in water by heating. Add agar and 
dissolve it in steamer. Adjust pH to 7.5. Add lactose and neutral red shake well 
and mix. Heat in free steam (100°C) for 1 hour, then autoclave at 115°C for 
15minutes. 
2. Blood agar (5% sheep blood agar) 
Peptone     l0g 
NaCl      5g 
Distilled water    1 Ltr 
Agar      10g 
       Dissolve ingredients in distilled water by boiling, and add 5% sheep 
blood(sterile) at 55°C adjust pH to 7.4. 
3. Chocolate agar 
Sterile defibrinated blood  10 ml 
Nutrient Agar (melted)  100 ml 
When the temperature was about 75°C, sterile blood was added with 
constant agitation. After addition of blood, kept in water bath and heating was 
continued till the blood changed to chocolate colour. Cooled to about 50° C 
and poured about 15ml into petri dishes with sterile precaution. 
4.Sabouraud dextrose agar 
Dextrose    40g 
Peptone     l0g 
Agar                20g 
Distilled water    l000ml 
 
 
pH = 5.6 
Sterilise by autoclaving at 121ºC for 20 min 
5. Mueller Hinton Agar: 
Beef, infusion   300ml 
Casein acid hydrolysate  17.5g 
Starch      1.5g 
Agar      10g 
Distilled water                                 1 litre 
Final pH (at 25°C) 7.3±0.1 
Sterilize by autoclaving at 15 lbs pressure (121°C) for 15 minutes. 
6.Corn meal agar 
Ingredients       
Corn meal              8gm 
Agar     4gm 
Distilled water   200ml 
Tween 80(1%)   2ml 
Heat corn meal and water at 600C for 1 hour and filter through filter 
paper. Add distilled water and agar. Autoclave it at 1210C for 15 minutes and 
pour in lates. Cornmeal tween agar is prepared by adding Tween 80 before 
autoclaving.  
7.RPMI 1640 Medium 
           RPMI 1640 medium buffered with 0.165 mol/L MOPS, 1 L10.4 g 
powdered RPMI 1640 medium (with glutamine and phenol red, without 
 
 
bicarbonate) 34.53 g MOPS (3-[N-morpholino] propanesulfonic acid) buffer. 
Dissolve powdered medium in 900 mL distilled H2O. Add MOPS (final 
concentration of 0.165 mol/L) and stir until dissolved. While stirring, adjust the 
pH to 7.0 at 250C using 1 mol/L sodium hydroxide. Add additional water to 
bring medium to a final volume of 1 L. Filter sterilize and store at 4 °C until 
use. 
C.MEDIA AND REAGENTS REQUIRED FOR BIOCHEMICAL 
IDENTIFICATION: 
 
1.Oxidase Reagent 
     Tetra methyl p-phenylenediaminedihyrochloride- 1% aqueous solution. 
2.Catalase test 
3% hydrogen peroxide 
3.Indole test 
Kovac’s reagent 
Amyl or isoamyl alcohol     150ml 
Para dimethyl amino benzaldehyde  10g 
Concentrated hydrochloric acid    50ml 
Dissolve the aldehyde in the alcohol and slowly add the acid. Prepare in 
small quantities and store in the refrigerator. Shake gently before use. 
4. Christensen’s Urease test medium 
Peptone      1g 
Sodium chloride     5g 
Dipotassium hydrogen phosphate   2g 
Phenol red      6ml 
 
 
Agar       20g 
Distilled water     1 ltr 
10% sterile solution of glucose   l0ml 
Sterile 20% urea solution    l00ml 
Sterilize the glucose and urea solutions by filtration. Prepare the basal 
medium without glucose and urea, adjust to pH 6.8-6.9 and sterilize by 
autoclaving in a flask at 121°C for 30min. Cool to about 50°C, add the glucose 
& urea, and tube the medium as slopes. 
5. Simmon’s Citrate Medium 
Koser’s medium     1 ltr 
Agar       20g 
Bromothymol blue     0.2% 40ml 
Dispense, autoclave at 121°C for 15 min and allow to set as slopes 
6.Triple Sugar Iron medium 
Beef extract     3g 
Yeast extract    3g 
Peptone     20g 
Glucose     1g 
Lactose    l0g 
Sucrose    l0g 
Ferric citrate     0.3g 
Sodium chloride   5g 
Sodiumthiosulphate   0.3g 
Agar     12g 
 
 
Phenol red 0.2% solution  l2ml 
Distilled water    1 ltr 
Heat to dissolve the solids, add the indicator solution, mix and 
tube.Sterilize at 121°C for 15 min and cool to form slopes with deep butts. 
7.Glucose phosphate broth 
Peptone      5g 
Dipotassium hydrogen phosphate  5g 
Water      1 ltr 
Glucose 10% solution   50ml 
Dissolve the peptone and phosphate and adjust the pH to 7.6. Filter 
dispense in 5ml amounts and sterilize at 121°C for 15min. Sterilize the glucose 
solution by filtration and add 0.25ml to each tube 
Methyl Red Reagent 
Methyl Red      10mg 
Ethyl alcohol     30ml 
Distilled water    20ml 
VogesProskauer Reagent 
Reagent A:  
Alpha naphthol   5g 
Ethyl alcohol    100ml 
 
Reagent B:  
Potassium hydroxide   40g 
Distilled water    100ml 
 
 
8. Peptone water fermentation test medium. 
To the basal medium of peptone water, add sterilised sugars, 
1%indicator bromothymol blue with Durham’s tube. 
Basal medium peptone water 
Sugar solutions: 
Sugar      1ml 
Dislilled water    l00ml 
pH = 7.6. 
9. Potassium nitrate broth 
Potassium nitrate (KN03)   0.2gm 
Peptone     5.0gm 
Distilled water    100ml 
The above ingredients were mixed and transferred into tubes in 5 ml amount 
and autoclave. 
10.Decarboxylase media: 
10a.Moeller decarboxylase broth base: 
Ingredients     gms/L 
Peptone    5 
Beef extract    5 
Bromocresol purple   0.01 
Cresol red    0.005 
Glucose    0.5 
Pyridoxal    0.005 
Final pH 6 
 
 
10b. Aminoacid: 
Add 10 g of the levo form of the amino acid for 1000ml.mix and 
dispense in sterile tubes. 
11. Hugh&Leifson’s Oxidation –Fermentation test: 
Peptone     2g 
Sodium chloride     5g 
D-glucose                10g 
Bromothymol blue     0.03g 
Agar       3.0g 
Dipotassium phosphate   0.30g 
Distilled water     1L 
pH =7.1 
Basal medium is autoclaved.1% of sterile sugar solutions is added to the 
basal medium. Dispense into sterile test tubes without slant. 
12. Phenolphthalein diphosphate agar 
Sterilize 1% aqueous solution of sodium phenolphthalein diphosphate 
by filtration and store at 4ºC.Add 10ml of this solution to 1000ml melted 
nutrient agar cooled to 50ºCand pour plates. Grow the staphylococcus 
overnight at 37ºC on the medium. Invert the plate and pour a few drops of 
ammonia solution SG 0.88 in to the lid. Read as positive a culture whose 
colonies turn bright pink within a few minutes. The colour soon fades. 
 
 
 
 
ANNEXURE - I 
 
 
 
ANNEXURE - II 
PROFORMA 
 
Name  :    IP /OP no : 
Age  :    Sex  :  
Address :    Occupation :             
 
 
Present Complaints and duration : 
 
Past history    :  
 
Personal history   : 
 
Treatment history   : 
 
Clinical diagnosis   : 
Microbiological investigation  
Specimen collected   : 
Direct examination   : 
Direct Gram stain  : 
KOH mount    : 
Bacterial Culture 
      MacConkey agar  : 
           Blood agar   : 
           Chocolate agar  : 
 
Culture Gram stain   : 
Motility    : 
Catalase test    : 
Coagulase test   : 
Oxidase test    : 
 
 
Biochemical reactions  : 
 
 
 
Isolate identified in sample  : 
Antibiotic susceptibility pattern : 
 
 
Fungal culture   : 
Sabouraud’s dextrose agar  : 
 
Lactophenol Cotton Blue mount  : 
 
Gram stain     : 
Isolate identified in sample   : 
Antifungal susceptibility pattern  : 
  
 
 
 
 
 
 
  
 
 
ANNEXURE - III 
PATIENT CONSENT FORM 
Title of the study:"A STUDY ON BACTERIAL AND FUNGAL 
INFECTIONS IN PATIENTS WITH DACRYOCYSTITIS IN A 
TERTIARY CARE HOSPITAL". 
Name :      Date   : 
Age :      OP/IP No  :  
Sex :      Project Patient No : 
Documentation of the informed consent 
I _____________________________ have read the information in this form 
(or it has been read to me). I was free to ask any questions and they have been 
answered. I hereby give my consent to be included as a participant in “A 
STUDY ON BACTERIAL AND FUNGAL INFECTIONS IN PATIENTS 
WITH DACRYOCYSTITIS IN A TERTIARY CARE HOSPITAL”. 
1. I have read and understood this consent form and the information provided 
to me. 
2. I have had the consent document explained to me. 
3. I have been explained about the nature of the study. 
4. I have been explained about my rights and responsibilities by the 
investigator.  
5. I have been informed the investigator of all the treatments I am taking or 
have taken in the past ________ months including any native (alternative) 
treatment. 
6. I have been advised about the risks associated with my participation in this 
study. 
7. I agree to cooperate with the investigator and I will inform him/her 
immediately if I suffer unusual symptoms. 
8. I have not participated in any research study within the past ________ 
month(s). 
 
 
9. I am aware of the fact that I can opt out of the study at any time without 
having to give my reason and this will not affect my future treatment in this 
hospital. 
10. I am also aware that the investigator may terminate my participation in the 
study at any time, for any reason, without any consent. 
11. I hereby give permission to the investigators to release the information 
obtained from me as result of participation in this study to the sponsors, 
regulatory authorities, Govt. agencies, and IEC. I understand that they are 
publicly presented. 
12. I have understood that my identity will be kept confidential if my data are 
publicly presented. 
13. I have had my questions answered to my satisfaction. 
14. I have decided to be in the research study. I also give my consent to give 
my clinical specimen(purulent discharge from lacrimal punctum) for further 
investigations. 
 
I am aware that if I have any question during this study, I should contact the 
investigator. By signing this consent form I attest that the information given in 
this document has been clearly explained to me and understood by me, I will be 
given a copy of this consent document. 
Name and signature / thumb impression of the participant (For age <17 years-
Name& signature of the parent/guardian) 
Name ___________________________________ 
Signature_________________________  
Date________________ 
 
 
Name and Signature of the investigator  
Name ___________________________________ 
Signature_________________________  
Date________________
 
 
ANNEXURE – IV 
MASTER CHART 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
KEY TO MASTER CHART 
S  - Sensitive 
R  - Resistant 
N  - Not tested 
ORG 1 - Organism 1 
ORG-2 - Organism 2 
AK  - Amikacin 
Ox  - Oxacillin 
Cx  - Cefoxitin 
Ery  - Erythromycin 
Cip  - Ciprofloxacin 
Gati  - Gatifloxacin 
TMP-SMX - Trimethoprim-Sulfamethoxazole 
Gen  - Gentamicin 
Tob  - Tobramycin 
CTX  - Cefotaxime 
CAZ  - Ceftazidime 
Pen  - Penicillin 
Tetra  - Tetracycline 
Amp  - Ampicillin 
Chlor  - Chloramphenicol 
PT  - Piperacillin-tazobactam 
Van  - Vancomycin 
Flu  - Fluconazole 
Itra  - Itraconazole 
Ampho - Amphotericin B 
Vori  - Voriconazole 
M  - Male 
F  - Female 
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